BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19224499)

  • 1. Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery.
    Jurczyńska J; Stepień T; Lawnicka H; Stepień H; Krupiński R; Kołomecki K; Kuzdak K; Komorowski J
    Endokrynol Pol; 2009; 60(1):9-13. PubMed ID: 19224499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of determining the serum concentrations of vascular endothelial growth factor (VEGF) and its soluble receptor type 2 (sVEGF-2) in the differential diagnosis of adrenal incidentalomas.
    Foltyn W; Strzelczyk J; Marek B; Kajdaniuk D; Siemińska L; Rosiek V; Kos-Kudła B
    Endokrynol Pol; 2012; 63(1):22-8. PubMed ID: 22378094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
    Kolomecki K; Stepien H; Bartos M; Kuzdak K
    Endocr Regul; 2001 Mar; 35(1):9-16. PubMed ID: 11308991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery.
    Shantha Kumara HM; Cabot JC; Hoffman A; Luchtefeld M; Kalady MF; Hyman N; Feingold D; Baxter R; Whelan RL
    Surg Endosc; 2010 Feb; 24(2):283-9. PubMed ID: 19551437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of pro- and antiangiogenic factors blood serum concentrations in patients with hormonal inactive adrenal tumors].
    Korzeniewska M; Kołomecki K; Stepień H; Naze M; Stepień T; Kuzdak K
    Endokrynol Pol; 2005; 56(1):39-44. PubMed ID: 16335673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and basic fibroblast growth factor evaluation in blood serum of patients with hormonally active and inactive adrenal gland tumours.
    Kołomecki K; Stepień H; Narebski JM
    Cytobios; 2000; 101(396):55-64. PubMed ID: 10697745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive colon resection is associated with a transient increase in plasma sVEGFR1 levels and a decrease in sVEGFR2 levels during the early postoperative period.
    Shantha Kumara HM; Cabot JC; Hoffman A; Luchtefeld M; Kalady MF; Hyman N; Feingold D; Baxter R; Whelan RL
    Surg Endosc; 2009 Apr; 23(4):694-9. PubMed ID: 19184203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble receptors for vascular endothelial growth factor (sVEGFR1/sVEGFR2) in infantile hemangioma.
    Przewratil P; Sitkiewicz A; Andrzejewska E
    Growth Factors; 2010 Dec; 28(6):417-25. PubMed ID: 20854187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery.
    Komorowski J; Jurczynska J; Stepien T; Kolomecki K; Kuzdak K; Stepien H
    Int J Mol Sci; 2010 May; 11(6):2281-90. PubMed ID: 20640152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma levels of tissue factor as a valuable diagnostic biomarker with relevant efficacy for prediction of breast cancer morbidity.
    Zarychta E; Rhone P; Bielawski K; Rosc D; Szot K; Zdunska M; Ruszkowska-Ciastek B
    J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
    Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of circulating vascular endothelial growth factor and its soluble receptors in patients with different forms of chronic urticaria.
    Jagodzinska J; Polaniak R; Birkner E; Kasperska-Zajac A
    Biomed Res Int; 2015; 2015():578383. PubMed ID: 25756047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
    Kirman I; Belizon A; Balik E; Feingold D; Arnell T; Horst P; Kumara S; Cekic V; Jain S; Nasar A; Whelan RL
    Eur J Surg Oncol; 2007 Dec; 33(10):1169-76. PubMed ID: 17512160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
    Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
    Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
    Hu Q; Dey AL; Yang Y; Shen Y; Jilani IB; Estey EH; Kantarjian HM; Giles FJ; Albitar M
    Cancer; 2004 May; 100(9):1884-91. PubMed ID: 15112269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected angiogenic factors in plasma of patients with lower limb symptomatic peripheral arterial disease: preliminary report.
    Wieczór R; Gadomska G; Góralczyk B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
    Int Angiol; 2015 Dec; 34(6):545-51. PubMed ID: 25394959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women.
    Jesmin S; Akter S; Rahman MM; Islam MM; Islam AM; Sultana SN; Mowa CN; Yamaguchi N; Okazaki O; Satoru K; Kimura S; Hiroe M; Mizutani T; Moroi M
    Thromb Haemost; 2013 Apr; 109(4):696-705. PubMed ID: 23364276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
    Pietrowski D; Szabo L; Sator M; Just A; Egarter C
    Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.